已收盘 12-19 16:00:00 美东时间
-0.065
-0.47%
【民生能源】 2025年10月8日-10月10日 1 本周观点 本周行业动态分析 加沙停火,原油地缘溢价效应减弱。由于特朗普9月29日宣布以色列...
10-13 08:52
登录新浪财经APP 搜索【信披】查看更多考评等级 每天三分钟公告很轻松 海南华铁(603300):股东胡丹锋终止减持计划并拟增持公司股份;永...
10-08 22:20
来源:上海证券报·中国证券网 永和股份:前三季度净利润同比预增211.59%-225.25% 上证报中国证券网讯(记者 骆民)永和股份披露前三季度业绩预增公告...
10-08 22:09
美股周二早盘,独立天然气与油井运营商多样化能源公司(Diversified Energy,DEC)股价上涨5.6%,此前该公司已同意以约5.5亿美元的现金和股票收购Canvas能源公司。 此次收购将扩大多样化能源公司在阿纳达科盆地中部的业务组合,新增2.4万桶油当量/日的产量以及具有商业吸引力的未开发区域。该交易将通过增发新股和现有流动资金进行融资。 海量资讯、精准解读,尽在新浪财经APP 责任编辑:张俊 SF065
09-09 22:47
金吾财讯 | 威胜控股(03393)公布,公司于墨西哥成立的全资附属公司WASION,S.DER.L.DEC.V.(“威胜墨西哥”)于2025年6月26日就夺得价值逾6.27亿墨西哥披索(含税,折合逾人民币2.38亿元或2.64亿港元)的智能电表招标合约,与墨西哥联邦电力委员会(“CFE”)订立供货协议。 此外,威胜墨西哥亦于2025年3月二十五日与CFE签订价值逾14.53亿墨西哥披索(含税,折合逾人民币5.52亿元或6.1亿港元)的智能电表供货协议。
06-26 16:45
U.S. energy firm Diversified Energy and Carlyle announce $2 billion strategic partnership to invest in natural gas and oil assets. The deal combines Carlyle's financial expertise with Diversified's operational capabilities to enhance acquisition and optimize cash flow.
06-23 20:31
Diversified Energy Company PLC announced a Q4 2024 dividend of 29 cents per share to be paid on June 30, 2025, to shareholders registered on May 30, 2025. GBP dividends will be 21.254 pence per share, based on the June 12, 2025, exchange rate (GBP 0.73288 = US $1.00).
06-16 06:00
Diversified Energy Company PLC has repurchased 52,701 Ordinary Shares at a volume-weighted average price of $13.9435 per Share through Mizuho Securities USA LLC. The Shares will be cancelled, reducing the total issued Ordinary Shares to 78,704,313.
06-05 06:01
Projects aim to be responsive to the energy needs of data centers by offering an abundant supply of operational power within two yearsProjects target the provision of on-site, continuous, and scalable power generation,
03-10 15:59
U.S. stock futures were lower this morning, with the Nasdaq futures dipping around 100 points on Tuesday. Shares of Dyne Therapeutics, Inc. (NYSE:DYN) fell sharply in today's pre-market trading after the company announced new clinical data from its ongoing Phase 1/2 DELIVER trial of DYNE-251 in pati...
2024-09-03 20:03